Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666341 | PMC |
| http://dx.doi.org/10.3324/haematol.2015.132035 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Developing a Charlson Comorbidity Index for the American Indian Population Using the Epidemiologic Data from the Strong Heart Study.
J Racial Ethn Health Disparities
December 2024
Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Background: The Charlson Comorbidity Index (CCI) is a frequently used mortality predictor based on a scoring system for the number and type of patient comorbidities health researchers have used since the late 1980s. The initial purpose of the CCI was to classify comorbid conditions, which could alter the risk of patient mortality within a 1-year time frame. However, the CCI may not accurately reflect risk among American Indians because they are a small proportion of the US population and possibly lack representation in the original patient cohort.
View Article and Find Full Text PDFAnesthetists' Knowledge, Attitude, and related Factors on Patient Safety in Government Hospitals in Ethiopia a Multicenter Approach.
Sci Rep
December 2024
Departmment of Anesthesia, College of Medicine and Health Sciences, Addis Abeba University, Addis Abeba, Ethiopia.
In the field of healthcare, ensuring patient safety is a critical priority that has garnered global recognition as a pressing public health concern. Despite notable progress in medical treatments and diagnostic technologies, patients continue to be at risk of adverse events and harm during the perioperative period. Anesthetists hold a pivotal position in this phase of patient care and have the potential to greatly impact safety and outcomes.
View Article and Find Full Text PDFPapillary Renal Neoplasm With Reverse Polarity: CT and MR Imaging Characteristics in 26 Patients.
Acad Radiol
December 2024
Department of Radiology, the First Medical Center of the Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing 100853, China (X.W., H.K., X.B., X.N., C.L., S.Y., H.W.). Electronic address:
Rationale And Objectives: To improve the diagnostic recognition of papillary renal neoplasm with reverse polarity (PRNRP) through comprehensive analysis of computed tomography (CT) and magnetic resonance imaging (MRI) findings.
Materials And Methods: A retrospective multi-center study was conducted on patients with pathologically confirmed PRNRPs from 2019 to 2024, encompassing six institutions. Clinical and pathological data were meticulously documented.
Identification of D842V mutation in gastrointestinal stromal tumors based on CT radiomics: a multi-center study.
Cancer Imaging
December 2024
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Pujian Road 160, Pudong District, 200127, Shanghai, China.
Background: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. Recent advent of tyrosine kinase inhibitors (TKIs) has significantly improved the prognosis of GIST patients. However, responses to TKI therapy can vary depending on the specific gene mutation.
View Article and Find Full Text PDFIntraoperative Molecular Imaging With Pafolacianine: Histologic Characteristics of Identified Nodules.
Clin Lung Cancer
November 2024
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH. Electronic address:
Background: With increased early detection efforts, surgery for early-stage lung cancer is expected to rise. Pafolacianine is the first FDA approved targeted optical imaging agent indicated as an adjunct for intraoperative identification of malignant and nonmalignant pulmonary lesions in adult patients with known or suspected cancer in the lung.
Methods: This is a retrospective review of the malignant and nonmalignant lesions identified by pafolacianine with intraoperative molecular imaging (IMI) in the multi-center Phase 2 and Phase 3 ELUCIDATE clinical trials.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!